EMCDDA Home
  • EN
Search

Published: 10 November 2010

Table 3: Prevalence of cannabis use in the general population — summary of the data

Age group

Time frame of use

Lifetime

Last year

Last month

European prevalence estimates are based on weighted averages from the most recent national surveys conducted from 2001 to 2008/09 (mainly 2004–08), and therefore cannot be attached to a single year. The average prevalence for Europe was computed by a weighted average according to the population of the relevant age group in each country. In countries for which no information was available, the average EU prevalence was imputed. Populations used as basis: 15–64 (334 million), 15–34 (133 million) and 15–24 (63 million). The data summarised here are available under General population surveys in the 2010 statistical bulletin.

15–64 years Estimated number of users in Europe 75.5 million 23 million 12.5 million
European average 22.5 % 6.8 % 3.7 %
Range 1.5–38.6 % 0.4–15.2 % 0.1–8.5 %
Lowest-prevalence countries Romania (1.5 %) 
Malta (3.5 %) 
Cyprus (6.6 %) 
Bulgaria (7.3 %)   
Romania (0.4 %) 
Malta (0.8 %) 
Greece (1.7 %) 
Sweden (1.9 %)   
Romania (0.1 %) 
Malta, Sweden (0.5 %) 
Greece, Poland (0.9 %) 
Lithuania, Hungary (1.2 %)   
Highest-prevalence countries Denmark (38.6 %)
Czech Republic (34.2 %)
Italy (32.0 %)
United Kingdom (31.1 %)
Czech Republic (15.2 %)
Italy (14.3 %)
Spain (10.1 %)
France (8.6 %)

Czech Republic (8.5 %)
Spain (7.1 %)
Italy (6.9 %)
France (4.8 %)

15–34 years Estimated number of users in Europe 42 million 17 million 9.5 million
European average 31.6 % 12.6 % 6.9 %
Range 2.9–53.3 % 0.9–28.2 % 0.3–16.7 %
Lowest-prevalence countries Romania (2.9 %)
Malta (4.8 %)
Cyprus (9.9 %)
Greece (10.8 %)
Romania (0.9 %)
Malta (1.9 %)
Greece (3.2 %)
Cyprus (3.4 %)
Romania (0.3 %)
Sweden (1.0 %)
Greece (1.5 %)
Poland (1.9 %)
Highest-prevalence countries Czech Republic (53.3 %)
Denmark (48.0 %)
France (43.6 %)
United Kingdom (40.5 %)
Czech Republic (28.2 %)
Italy (20.3 %)
Spain (18.8 %)
France (16.7 %)

Czech Republic (16.7 %)
Spain (13.4 %)
Italy (9.9 %)
France (9.8 %)

15–24 years Estimated number of users in Europe 19.5 million 10 million 5.5 million
European average 30.9 % 16.0 % 8.4 %
Range 3.7–58.6 % 1.5–37.3 % 0.5–22.4 %
Lowest-prevalence countries Romania (3.7 %)
Malta (4.9 %)
Cyprus (6.9 %)
Greece (9.0 %)
Romania (1.5 %)
Greece, Cyprus (3.6 %)
Sweden (4.9 %)
Portugal (6.6 %)
Romania (0.5 %)
Greece, Sweden (1.2 %)
Cyprus (2.0 %)
Poland (2.5 %)
Highest-prevalence countries Czech Republic (58.6 %)
France (42.0 %)
Denmark (41.1 %)
Germany (39.0 %)
Czech Republic (37.3 %)
Spain (24.1 %)
Italy (22.3 %)
France (21.7 %)
Czech Republic (22.4 %)
Spain (16.9 %)
France (12.7 %)
Italy (11.0 %)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. Read more >>

Contact us

EMCDDA
Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 27 October 2010